"Anemia, Sickle Cell" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S.
| Descriptor ID |
D000755
|
| MeSH Number(s) |
C15.378.071.141.150.150 C15.378.420.155 C16.320.070.150 C16.320.365.155
|
| Concept/Terms |
Anemia, Sickle Cell- Anemia, Sickle Cell
- Anemias, Sickle Cell
- Sickle Cell Anemias
- Hemoglobin S Disease
- Disease, Hemoglobin S
- Hemoglobin S Diseases
- Sickle Cell Anemia
- Sickle Cell Disorders
- Cell Disorder, Sickle
- Cell Disorders, Sickle
- Sickle Cell Disorder
- Sickling Disorder Due to Hemoglobin S
- HbS Disease
- Sickle Cell Disease
- Cell Disease, Sickle
- Cell Diseases, Sickle
- Sickle Cell Diseases
|
Below are MeSH descriptors whose meaning is more general than "Anemia, Sickle Cell".
- Diseases [C]
- Hemic and Lymphatic Diseases [C15]
- Hematologic Diseases [C15.378]
- Anemia [C15.378.071]
- Anemia, Hemolytic [C15.378.071.141]
- Anemia, Hemolytic, Congenital [C15.378.071.141.150]
- Anemia, Sickle Cell [C15.378.071.141.150.150]
- Hemoglobinopathies [C15.378.420]
- Anemia, Sickle Cell [C15.378.420.155]
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
- Genetic Diseases, Inborn [C16.320]
- Anemia, Hemolytic, Congenital [C16.320.070]
- Anemia, Sickle Cell [C16.320.070.150]
- Hemoglobinopathies [C16.320.365]
- Anemia, Sickle Cell [C16.320.365.155]
Below are MeSH descriptors whose meaning is more specific than "Anemia, Sickle Cell".
This graph shows the total number of publications written about "Anemia, Sickle Cell" by people in this website by year, and whether "Anemia, Sickle Cell" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 1 | 0 | 1 |
| 1994 | 1 | 0 | 1 |
| 1995 | 3 | 0 | 3 |
| 1996 | 3 | 0 | 3 |
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2000 | 1 | 0 | 1 |
| 2001 | 2 | 1 | 3 |
| 2002 | 2 | 0 | 2 |
| 2003 | 2 | 1 | 3 |
| 2004 | 3 | 0 | 3 |
| 2005 | 4 | 1 | 5 |
| 2006 | 4 | 0 | 4 |
| 2007 | 4 | 1 | 5 |
| 2008 | 5 | 0 | 5 |
| 2009 | 6 | 0 | 6 |
| 2010 | 8 | 0 | 8 |
| 2011 | 14 | 2 | 16 |
| 2012 | 4 | 0 | 4 |
| 2013 | 11 | 1 | 12 |
| 2014 | 6 | 1 | 7 |
| 2015 | 5 | 2 | 7 |
| 2016 | 8 | 1 | 9 |
| 2017 | 8 | 2 | 10 |
| 2018 | 8 | 1 | 9 |
| 2019 | 12 | 0 | 12 |
| 2020 | 13 | 0 | 13 |
| 2021 | 6 | 0 | 6 |
| 2022 | 18 | 0 | 18 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anemia, Sickle Cell" by people in Profiles.
-
Pediatric Sickle Cell Disease Patients on Hydroxyurea Have Higher Rates of Surgical Splenectomy. J Surg Res. 2023 Mar; 283:798-805.
-
A Review of Sickle Cell Disease-Reply. JAMA. 2022 11 15; 328(19):1979-1980.
-
Global perspectives on cellular therapy for children with sickle cell disease. Curr Opin Hematol. 2022 11 01; 29(6):275-280.
-
Adherence to NHLBI guidelines for the emergent management of vaso-occlusive episodes in children with sickle cell disease: A multicenter perspective. Am J Hematol. 2022 11; 97(11):E412-E415.
-
The NLRP3 inflammasome fires up heme-induced inflammation in hemolytic conditions. Transl Res. 2023 02; 252:34-44.
-
Inpatient palliative care use by patients with sickle cell disease: a retrospective cross-sectional study. BMJ Open. 2022 08 16; 12(8):e057361.
-
Health-related quality of life of patients with sickle cell disease aged 8-17 years at Kamuzu Central Hospital, Malawi. Pediatr Blood Cancer. 2022 10; 69(10):e29876.
-
Sickle Cell Disease: A Review. JAMA. 2022 07 05; 328(1):57-68.
-
Is urgent surgical management necessary for priapism in pediatric patients with hematologic conditions? J Pediatr Urol. 2022 08; 18(4):528.e1-528.e6.
-
Neutrophil gelatinase-associated lipocalin is elevated in children with acute kidney injury and sickle cell anemia, and predicts mortality. Kidney Int. 2022 10; 102(4):885-893.